Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIa Trial Evaluating the Safety of Intratumoral Injection of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma

NCT03077685 is registered in ClinicalTrials.gov with NanOlogy, LLC as lead sponsor.

NCT NCT03077685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03077685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIa Trial Evaluating the Safety of Intratumoral Injection of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma
Lead sponsor
NanOlogy, LLC
Phase
Phase 2
Overall status
Completed
Start date
December 1, 2017
Completion date
March 15, 2023
Enrollment
54 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced pancreatic adenocarcinoma